Andrew D. Burdick

1.3k total citations
16 papers, 1.1k citations indexed

About

Andrew D. Burdick is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andrew D. Burdick has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Andrew D. Burdick's work include Peroxisome Proliferator-Activated Receptors (4 papers), RNA Interference and Gene Delivery (3 papers) and Virus-based gene therapy research (2 papers). Andrew D. Burdick is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), RNA Interference and Gene Delivery (3 papers) and Virus-based gene therapy research (2 papers). Andrew D. Burdick collaborates with scholars based in United States, Germany and France. Andrew D. Burdick's co-authors include Jeffrey M. Peters, Frank J. Gonzalez, Marjorie A. Peraza, Scott W. Burchiel, John W. Davis, Ke Jian Liu, Honglian Shi, Laurie G. Hudson, Fredine T. Lauer and Dae Joon Kim and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Archives of Biochemistry and Biophysics.

In The Last Decade

Andrew D. Burdick

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew D. Burdick United States 12 710 255 141 110 94 16 1.1k
Ehab H. Sarsour United States 19 841 1.2× 224 0.9× 121 0.9× 187 1.7× 128 1.4× 38 1.5k
Amanda L. Kalen United States 21 908 1.3× 336 1.3× 134 1.0× 184 1.7× 168 1.8× 44 1.7k
Carlos Fernández Spain 20 608 0.9× 164 0.6× 107 0.8× 64 0.6× 172 1.8× 24 1.3k
Valentina Bosello Travain Italy 19 1.2k 1.7× 462 1.8× 84 0.6× 71 0.6× 112 1.2× 33 2.0k
Laurie Tsuruda United States 14 576 0.8× 130 0.5× 172 1.2× 196 1.8× 172 1.8× 20 1.2k
Wolfgang A. Schmalix Germany 20 464 0.7× 275 1.1× 66 0.5× 123 1.1× 172 1.8× 35 1.0k
Akira Ootsuyama Japan 16 808 1.1× 415 1.6× 93 0.7× 84 0.8× 220 2.3× 52 1.4k
Quentin Felty United States 17 604 0.9× 212 0.8× 187 1.3× 110 1.0× 158 1.7× 49 1.2k
Hakan Akça Türkiye 16 677 1.0× 281 1.1× 63 0.4× 101 0.9× 245 2.6× 60 1.3k
Katriina Kahlos Finland 19 649 0.9× 193 0.8× 47 0.3× 120 1.1× 151 1.6× 24 1.1k

Countries citing papers authored by Andrew D. Burdick

Since Specialization
Citations

This map shows the geographic impact of Andrew D. Burdick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Burdick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Burdick more than expected).

Fields of papers citing papers by Andrew D. Burdick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Burdick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Burdick. The network helps show where Andrew D. Burdick may publish in the future.

Co-authorship network of co-authors of Andrew D. Burdick

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Burdick. A scholar is included among the top collaborators of Andrew D. Burdick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Burdick. Andrew D. Burdick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Burdick, Andrew D., Annick Cauvin, Anthony M. DeLise, et al.. (2025). Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider. Regulatory Toxicology and Pharmacology. 158. 105793–105793. 1 indexed citations
2.
Qiu, Luping, Steven W. Kumpf, Elias M. Oziolor, et al.. (2025). In vitro NIH3T3 mouse embryonic fibroblast cell model does not predict AAV2 or AAVdj-mediated cell transformation. Toxicology and Applied Pharmacology. 495. 117229–117229. 2 indexed citations
3.
Kopec, Anna K., Ryuji Yokokawa, Nasir Khan, et al.. (2021). Microphysiological systems in early stage drug development: Perspectives on current applications and future impact. The Journal of Toxicological Sciences. 46(3). 99–114. 22 indexed citations
4.
LaBranche, Timothy P., Anna K. Kopec, Srinivasa R. Mantena, et al.. (2020). Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat Model. Toxicologic Pathology. 48(8). 994–1007. 2 indexed citations
5.
Burdick, Andrew D., Simone Sciabola, Srinivasa R. Mantena, et al.. (2014). Sequence motifs associated with hepatotoxicity of locked nucleic acid—modified antisense oligonucleotides. Nucleic Acids Research. 42(8). 4882–4891. 114 indexed citations
6.
Kakiuchi-Kiyota, Satoko, Petra Koza‐Taylor, Srinivasa R. Mantena, et al.. (2013). Comparison of Hepatic Transcription Profiles of Locked Ribonucleic Acid Antisense Oligonucleotides: Evidence of Distinct Pathways Contributing to Non-target Mediated Toxicity in Mice. Toxicological Sciences. 138(1). 234–248. 41 indexed citations
7.
Hollingshead, Brett D., et al.. (2013). High‐Throughput Gene Silencing and mRNA Expression Analysis in Hepatocyte Sandwich Cultures. Current Protocols in Toxicology. 55(1). Unit 14.11–Unit 14.11. 2 indexed citations
8.
Burdick, Andrew D., Moses T. Bility, Andrew N. Billin, et al.. (2007). Ligand activation of peroxisome proliferator-activated receptor-β/δ(PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes. Cellular Signalling. 19(6). 1163–1171. 71 indexed citations
9.
Müller‐Brüsselbach, Sabine, Martin Kömhoff, Wolfgang Meißner, et al.. (2007). Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ‐deficient mice. The EMBO Journal. 26(15). 3686–3698. 84 indexed citations
10.
Burdick, Andrew D., Irena Ivnitski‐Steele, Fredine T. Lauer, & Scott W. Burchiel. (2006). PYK2 mediates anti-apoptotic AKT signaling in response to benzo[a]pyrene diol epoxide in mammary epithelial cells. Carcinogenesis. 27(11). 2331–2340. 38 indexed citations
11.
Shi, Honglian, Graham S. Timmins, Andrew D. Burdick, et al.. (2005). Evaluation of spin trapping agents and trapping conditions for detection of cell-generated reactive oxygen species. Archives of Biochemistry and Biophysics. 437(1). 59–68. 92 indexed citations
12.
Peraza, Marjorie A., et al.. (2005). The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR). Toxicological Sciences. 90(2). 269–295. 215 indexed citations
13.
Burdick, Andrew D., Dae Joon Kim, Marjorie A. Peraza, Frank J. Gonzalez, & Jeffrey M. Peters. (2005). The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation. Cellular Signalling. 18(1). 9–20. 131 indexed citations
14.
Davis, John W., Andrew D. Burdick, Fredine T. Lauer, & Scott W. Burchiel. (2003). The aryl hydrocarbon receptor antagonist, 3′methoxy-4′nitroflavone, attenuates 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent regulation of growth factor signaling and apoptosis in the MCF-10A cell line. Toxicology and Applied Pharmacology. 188(1). 42–49. 31 indexed citations
15.
Burdick, Andrew D., John W. Davis, Ke Jian Liu, et al.. (2003). Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells.. PubMed. 63(22). 7825–33. 162 indexed citations
16.
Davis, John W., Fredine T. Lauer, Andrew D. Burdick, Laurie G. Hudson, & Scott W. Burchiel. (2001). Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: correlation with increased transforming growth factor alpha production.. PubMed. 61(8). 3314–20. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ehab H. Sarsour Breakdown of academic impact, for papers by Amanda L. Kalen Breakdown of academic impact, for papers by Carlos Fernández Breakdown of academic impact, for papers by Valentina Bosello Travain Breakdown of academic impact, for papers by Laurie Tsuruda Breakdown of academic impact, for papers by Wolfgang A. Schmalix Breakdown of academic impact, for papers by Akira Ootsuyama Breakdown of academic impact, for papers by Quentin Felty Breakdown of academic impact, for papers by Hakan Akça Breakdown of academic impact, for papers by Katriina Kahlos
Rankless by CCL
2026